Eledon Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
BVF PARTNERS L P/IL 10 percent owner
Pre-funded Warrants to Purchase Common Stock 2,213,816 $0 $2,214
Purchase
BVF PARTNERS L P/IL 10 percent owner
Pre-funded Warrants to Purchase Common Stock 2,100,244 $0 $2,100
Purchase
BVF PARTNERS L P/IL 10 percent owner
Pre-funded Warrants to Purchase Common Stock 440,489 $0 $440
Purchase
BVF PARTNERS L P/IL 10 percent owner
Common Stock, $0.001 par value 1,031,385 $2.37 $2,444,382
Purchase
BVF PARTNERS L P/IL 10 percent owner
Pre-funded Warrants to Purchase Common Stock 3,173,135 $0 $3,173
Purchase
BVF PARTNERS L P/IL 10 percent owner
Common Stock, $0.001 par value 821,121 $2.37 $1,946,057
Purchase
BVF PARTNERS L P/IL 10 percent owner
Pre-funded Warrants to Purchase Common Stock 2,526,238 $0 $2,526
Purchase
BVF PARTNERS L P/IL 10 percent owner
Pre-funded Warrants to Purchase Common Stock 232,068 $0 $232
Purchase
BVF PARTNERS L P/IL 10 percent owner
Common Stock, $0.001 par value 75,431 $2.37 $178,771
Purchase
BVF PARTNERS L P/IL 10 percent owner
Common Stock, $0.001 par value 1,055,445 $2.31 $2,438,078
Purchase
BVF PARTNERS L P/IL 10 percent owner
Common Stock, $0.001 par value 837,146 $2.31 $1,933,807
Purchase
BVF PARTNERS L P/IL 10 percent owner
Common Stock, $0.001 par value 86,341 $2.31 $199,448
Purchase
BVF PARTNERS L P/IL 10 percent owner
Pre-funded Warrants to Purchase Common Stock 2,028,645 $0 $2,029
Purchase
BVF PARTNERS L P/IL 10 percent owner
Warrants to Purchase Common Stock 2,446,209 $3 $7,338,627
Purchase
BVF PARTNERS L P/IL 10 percent owner
Warrants to Purchase Common Stock 252,291 $3 $756,873
Purchase
BVF PARTNERS L P/IL 10 percent owner
Pre-funded Warrants to Purchase Common Stock 1,609,063 $0 $1,609
Purchase
BVF PARTNERS L P/IL 10 percent owner
Pre-funded Warrants to Purchase Common Stock 165,950 $0 $166
Purchase
BVF PARTNERS L P/IL 10 percent owner
Warrants to Purchase Common Stock 3,084,090 $3 $9,252,270
Purchase
PERRIN STEVEN director, officer: President
Common Stock 1,000 $2.6 $2,597
Purchase
GROS DAVID-ALEXANDRE C director, officer: Chief Execut..
Common Stock 2,000 $4.48 $8,960
Purchase
GROS DAVID-ALEXANDRE C
Common Stock 4,000 $6.21 $24,840
Purchase
LITTLE PAUL SEAN
Common Stock 10,000 $8.87 $88,700
Purchase
GROS DAVID-ALEXANDRE C
Common Stock 3,000 $8.01 $24,030
Sale
ORBIMED ISRAEL GP LTD.
Common Stock 103,200 $21.6 $2,229,120
Purchase
LOGOS GLOBAL MANAGEMENT LP
Common Stock 79,098 $25.41 $2,009,564
Sale
LOGOS GLOBAL MANAGEMENT LP
Common Stock 12,969 $26.45 $343,030
Sale
CHIMOVITS EREZ
Warrants to Purchase Common Stock 646,204 $0.2 $129,241
Sale
ORBIMED ISRAEL GP LTD.
Warrants to Purchase Common Stock 646,204 $0.2 $129,241
Sale
FLESHER GREGORY J.
Common Stock 2,937 $1.91 $5,613
Sale
KUWAHARA JON
Common Stock 1,058 $1.91 $2,022
Sale
TURKEL CATHERINE C.
Common Stock 1,914 $1.91 $3,658
Sale
FLESHER GREGORY J.
Common Stock 11,701 $1.96 $22,957
Sale
KUWAHARA JON
Common Stock 4,218 $1.96 $8,276
Sale
TURKEL CATHERINE C.
Common Stock 7,623 $1.96 $14,956
Purchase
CHIMOVITS EREZ
Warrants to Purchase Common Stock 646,204 $3.1 $2,003,232
Purchase
ORBIMED ISRAEL GP LTD.
Common Stock 646,204 $3.1 $2,003,232
Purchase
ORBIMED ISRAEL GP LTD.
Warrants to Purchase Common Stock 646,204 $3.1 $2,003,232
Purchase
CHIMOVITS EREZ
Common Stock 646,204 $3.1 $2,003,232
Sale
LIFESCI INDEX PARTNERS LLC
Common Stock, par value $0.01 per share 200 $2.7 $540
Purchase
TURKEL CATHERINE C.
Common Stock 16,632 $5.02 $83,476
Purchase
TURKEL CATHERINE C.
Common Stock 17,048 $4.56 $77,671
Purchase
TURKEL CATHERINE C.
Common Stock 805 $3.97 $3,193

Showing 1 to 42 of 42 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.